*About Us
Learn about our laboratory's mission and core values.
We are committed to bridging the gap between companion animal and human oncology, from genome assemblies to precision cancer care and antibody drugs development.
Impact
We honor every sample by transforming it into insights that drive better cancer cares across species, not just data for data’s sake.
Equity
We strive to bring human-level cancer diagnostics and treatment options to every animal, closing the gap across species.
Compassion
We see the lives behind every diagnosis and stand alongside pet families with empathy, integrity, and care that goes beyond the lab.
Advanced Laboratory
Our lab generates multi-omics data from pet tumors to support precision diagnostics and power a growing database for cancer research.
In parallel, we cultivate patient-derived tumor organoids to predict drug responses and uncover resistance mechanisms. These insights feed directly into our antibody discovery pipeline, where novel therapeutic candidates are developed and validated using relevant organoids models.
By uniting sequencing, functional testing, and therapeutic development under one roof, we are transforming how cancer is understood and treated across species.
GCP Clinical Trial Centre
We operates a state-of-the-art Clinical Trial Center in Foshan, equipped with advanced medical technologies on par with leading human hospitals.
These cutting-edge tools form the foundation for precise diagnosis, advanced treatment, and high-level research in companion animal diseases, including oncology.
All clinical staff have completed GCP (Good Clinical Practice) training and are certified, ensuring we meet rigorous standards for conducting and overseeing independent veterinary clinical research.
High Performance Computing
Ocra Biotechnology Co., Limited
Unit 5-6, International Biomedical Industrial Park (Phase II), Shenzhen
